REPL

Levi & Korsinsky Reminds Replimune Group, Inc. Investors of

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - REPL

REPL Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Replimune Group, Inc. Securities Lawsuit - Contact SueWallSt

REPL Shareholder Alert: October 5, 2026 Lead Plaintiff Deadline in Replimune Group, Inc. Securities Class Action - Contact Levi & Korsinsky

Replimune Group, Inc. (REPL) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

REPL Stockholders Have Rights – If You Lost Money Investing

Robbins LLP Urges REPL Investors Who Lost Money Investing in Replimune to Contact the Firm for Information About Leading the Class Action

REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with SBS Law

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of October 5, 2026 in Replimune Group, Inc. Lawsuit - REPL

REPL Shareholder Alert: Replimune Group, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

Replimune group CEO Sushil Patel sells $510,252 in stock

Replimune Group Chief Executive Officer Sold Shares Worth Over $510K

Replimune prices $150M underwritten offering of common stock and pre-funded warrants

Wedbush upgrades Replimune stock rating on FDA approval

Replimune Group, Inc. (REPL) Shareholder/Analyst Call - Slideshow (NASDAQ:REPL) 2026-08-07